In patients with coronary artery disease, cardiac function is governed by the oxygen consumption of the myocardium and the oxygen available to the myocardium. The major determinants of cardiac oxygen demand are: heart rate, wall tension, and contractility: an increase in any or all of these increases the requirement for oxygen. Inevitably, this means that the risks of anaesthesia and surgery are increased in patients with coronary artery disease (Tarhan et al., 1972; Topkins and Artusio, 1964) . However, under clinical conditions it is difficult to evaluate precisely the effects of anaesthetic agents on myocardial ischaemia-for two main reasons: the extent of ischaemia varies greatly between individual patients, and it is impossible to delineate clearly regional changes in myocardial performance.
We have developed a model of myocardial ischaemia comparable to that obtained clinically, and have investigated the effects of enflurane on regional myocardial blood supply, regional myocardial function and regional myocardial metabolism during severe coronary stenosis.
MATERIALS AND METHODS
Investigations were undertaken on 14 mongrel dogs of either sex with a mean weight of 17.8 ± 5.1 kg. Nine dogs received enflurane in a concentration of 2.2 vol.% (1 MAC; enflurane group; EG) in air. Five animals received no enflurane and served as controls (control group; CG). Correspondence to K. v. A. 
SUMMARY

Anaesthesia
The dogs were premedicated with morphine 0.4 mg/kg body-weight) and propiolyl-promazine (Combelen) 0.2 mg kg' 1 i.m. Anaesthesia was induced with pentobarbitone sodium 15 mg kg" 1 i.v., and after tracheal intubation, the lungs were ventilated with 67% nitrous oxide in oxygen using a Drager Narkosespiromat at a rate of 12 b.p.m. Nitrous oxide was administered during the surgical preparation only. The dogs were then ventilated with an oxygen-air mixture (Flo 2 = 0.33) during the measurements. The arterial oxygen tension did not exceed 16 kPa and the mean carbon dioxide tension was 5.1 ± 0.27 kPa. Ventilation was monitored by blood-gas analysis (Eschweiler D33) at regular intervals. Any metabolic acidosis was corrected by administration of 8.4% sodium bicarbonate. Anaesthesia was maintained by hourly doses of pentobarbitone 3 mg kg" 1 . Core temperature was maintained at 37 ± 1 °Cby means of a heating pad. Fluid requirements during operation were supplied by lactated Ringer's solution i.v. Alcuronium was given before the thoracotomy.
Surgical preparation
A large polyethylene (PE) catheter was placed in the femoral vein to allow infusions and injections i.v. Another PE catheter, for continuous pressure measurements (Statham P23Db) was passed into the aortic arch via a femoral artery. Cardiac output was measured by the thermodilution method, the appropriate injection catheter being placed in the right atrium via the external jugular vein. The thermistor was passed into the aortic arch via a small branch of the femoral artery.
A thoracotomy was performed (fifth left intercostal space), the pericardium opened and the anterior interventricular branch of the left coronary artery (LAD) exposed immediately distal to its origin. Care was taken not to damage the closely adjacent coronary vein or the major descending arterial branches. An electromagnetic flowmeter (Statham SP2202) was fixed at this site, and a mechanical coronary constrictor with a micrometer screw gauge (Vetter and Mittmann, 1981) sited distal to the flowmeter. A flexible PE catheter was inserted, via the coronary sinus, to the great cardiac vein for selective collection of coronary venous blood from the LAD region (Obeid et al., 1972) . A surgical snare was used to compress the vein during blood sampling, and p r vent any backflow from the coronary sinus ( fig. 1 A microtip manometer (Millar PC35O) was plaa transmurally into the left ventricle to measure t) left ventricular pressure (LVP) and its first deriv tive (dp/di). A silicone catheter was tied into the k auricle for the injection of radioactive microspheres. The shortening of the regional muscle fibres was estimated with the aid of two ultrasonic crystals which were placed in the subendocardial layer of the area of myocardium supplied by the LAD ( fig. 1 ).
Haemodynamics
The following variables were recorded continuously on an eight-channel recorder (Brush Mk481): Lead II electrocardiogram (ECG) using needle electrodes, LVP, dpldt, left ventricular end-diastolic pressure (LVEDP), aortic pressure, coronary flow in the LAD (CF L AD)> and shortening of the regional muscle fibres in the area supplied by the LAD (AL).
Coronary perfusion pressure (CPP) was calculated as diastolic pressure minus the LVEDP. Cardiac contractility was estimated as the so-called Krayenbuehl contractility index (KI) and was calculated using the following formula (Krayenbuehl, 1967 (Krayenbuehl, , 1969 : IP where IP = instantaneously developed pressure.
Regional myocardial function
One pair of ultrasonic transducers (Parks Electronics, Beaverton, U.S.A.) was placed in the sub-endocardial layer at right angles to the axis of the heart (Franklin et al., 1973; Hagl et al., 1977) . The site was selected so that both crystals were placed in the area of the myocardium supplied by the LAD. By measuring continuously the ultrasound transit times between both crystals, it was possible to trace regional wall movement of the left ventricle quantitatively and qualitatively. The end-diastolic length (EDL) and the length at the end of the ventricular systole (ESL) were measured. As the distances between the crystals differed in the various experiments, these were standardized to a baseline segmental length of 10 mm by means of the following formula (Theroux et al., 1976) :
The extent of the segmental shortening during systole (AL) was calculated as the difference between EDL and ESL divided by EDL. AL was expressed in percent of the EDL. The standardization was carried out in accordance with the above formula.
Regional myocardial blood flow
Myocardial blood flow (MBF) was determined with the aid of tracer microspheres (Rudolph and Heymann, 1967) . Microspheres (3M Company) with a mean diameter of 8 urn and labelled with five different radioisotopes (iodine-125, cerium-58, chromium-51, strontium-85, scandium-46) were injected to the left atrium at the measuring times. During the injection of the microspheres, a reference blood sample was drawn through a catheter in the carotid artery the tip of which rested in the arch of the aorta (Domenech et al., 1969) .
When all measurements were completed, the LAD was ligated and the pressure was measured distal to the occlusion ("retro-pressure")-The ratio of the retro-pressure and mean aortic pressure (MAP) served as a measure of the collateral blood supply of the area supplied by the LAD. This ratio was invariably less than 0.3, that is there was no extensive collateral supply.
At the end of the experiment, the occluded LAD was injected with 20 ml of a saturated potassium chloride solution mixed with lissamine green. The green-stained part of the myocardial tissue represented the area supplied by the LAD. The heart was divided into several samples (Wirth et al., 1979) . Each sample was subdivided into three layers, subendocardium, myocardial third, and subepicardium and the MBF in each sample was determined by measurement of the radioactivity in relation to the reference blood sample.
Myocardial metabolism
In order to assess the metabolic processes in the ischaemic area of the myocardium, coronary venous blood was selectively sampled via the great cardiac vein from the region supplied by the LAD. The following variables were estimated in samples of arterial and coronary venous blood: the concentrations of potassium, sodium, lactate, pyruvate, CK-MB (Boehringer) and haemoglobin, the haematocrit, pH, PCO 2 , PO 2 , and oxygen content (Lexington Instruments, Waltham, U.S.A.).
Experimental procedure
The individual sections of the experimental procedure are shown in table I. MBF was determined (tracer microspheres) at points 2,4,6, 8 and 10. The control group (CG) received no enflurane at stages 5 and 6.
Statistics
The results are presented as means ± standard error of the mean (SEM). Differences between the mean values were evaluated for statistical significance by Student's paired and unpaired t tests, and were considered significant at P values ^ 0.05. (table II) The coronary stenosis had no effect on the mean aortic pressure (MAP) or the left ventricular pressure (LVP). The only reaction to the acute ischaemia (dp/dO/IP (s- was a slight, non-significant increase in the heart rate. LVEDP increased slightly in the enflurane group (EG) and in the control group (CG). Contractility (dp/dr^/IP) decreased significantly in both groups (EG by 14%: CG by 17%, P < 0.05). Cardiac output was unaffected, and total peripheral resistance (TSR) was unchanged. Coronary perfusion pressure (CPP) decreased slightly in the enflurane group following the stenosis.
RESULTS
Haemodynamic variables
The administration of enflurane 2.2 vol.% 20 min after the stenosis (episodes 5 and 6) was followed by effects similar to those described in the literature (Horan et al., 1977; Merin, Kumazawa and Luka, 1976) . MAP decreased from 113 ±6 mm Hg by 10% 10 min after enflurane to 102 ± 8 mm Hg, and at episode 6 by 13% to 98 ± 7 mm Hg (P < 0.05). Enflurane decreased CPP from 97 ± 6 to 81 ± 5 mm Hg (P < 0.05). Heart rate was reduced by a maximum of 11%. The TSR decreased by 14% (P < 0.05) during the administration of enflurane. All these values began to increase again after the withdrawal of the enflurane, showing that the effects were reversible.
Enflurane had no detectable effects on the LVEDP. Cardiac output tended to decrease after enflurane in isolated experiments, but the mean reduction was not significant.
Regional function ( fig. 2) A substantial increase in the end-diastolic length (EDL) was recorded 10 min after the stenosis. This was more pronounced in the enflurane group (27%; P < 0.001) than in the control group (18%; P < 0.001). Segmental shortening (AL), as a function of time, decreased significantly following stenosis in both groups (P < 0.05). Enflurane caused no decrease in AL. Discontinuation of enflurane was followed by an increase which did not occur in the control group at this time.
Myocardial blood flow
Regional myocardial blood flow decreased following the stenosis, especially in the inner layers of the ischaemic area-20% of the baseline value in the CG and 26% in the EG. Although the constriction was maintained at the same pressure, myocardial blood flow increased in all layers in the course of the experiment, especially in the subendocardial layers (endo), so that at experimental stage 8 (= 60 min after stenosis and 20 min after termination of the enflurane administration), MBF endo in the LAD distribution was only 45% of the baseline value in the CG and 41% in the EG (fig. 3 ). There was, however, no significant difference between the subendocardial blood flows (MBF endo ) m the two groups. The endo/epi ratio was unchanged during the ischaemic period in the LAD distribution, nor was it affected by enflurane (table III) .
The coronary vasoconstriction itself had no effect on the endo/epi ratio of the non-stenosed myocardium, that is, the region supplied by the circumflex coronary artery (CCA): there were no significant differences from baseline values. (fig. 4) After the onset of coronary stenosis, the normal myocardial lactate extraction was turned into lactate production in both groups. This lactate production decreased significantly after the administration of enflurane (P < 0.01). In contrast, in the control group a further discernible increase in lactate production was seen. After the withdrawal of enflurane, lactate extraction did not change, but remained nearly constant. The values in both groups returned to baseline values on release of the stenosis.
Myocardial metabolism
There were no changes in any given direction in other metabolic values, for example pyruvate, sodium and potassium concentrations. (o) and in the enflurane group (•). After the onset of the coronary stenosis lactate was produced in both groups. Enflurane reduced this lactate production, whereas a marked lactate output from the ischaemic area continued in the control group. Mean values ± SEM.
DISCUSSION
In this study, the effects of enflurane on regional myocardial variables were investigated in dogs in which the heart had been rendered acutely ischaemic.
In both groups, the administration of pentobarbitone 15 mg kg caused the well-known increase in heart rate. However, there were no significant differences between the control animals and the enflurane group before exposure to the volatile agent. Following the coronary stenosis, a further but insignificant increase in heart rate occurred (no further increments of pentobarbitone were given during the period of myocardial ischaemia).
The heart rate decreased to basal values during enflurane administration. In contrast, this variable remained increased in the control group. On the other hand, enflurane is known to reduce the total peripheral vascular resistance (Horan et al., 1977; van Ackern et al., 1979) . The global contractility, expressed as dp/dr max of the non-constricted left ventricle, was diminished as much in response to enflurane as in the ischaemic area, measured as regional change in contractility, AL. This means that, under the influence of enflurane, the nonaffected area as well as the ischaemic region contracts with reduced inotropism against a smaller afterload. These reductions in contractility and wall tension must result inevitably in a decrease of the myocardial oxygen consumption unless the myocardial depression is so severe that it causes a compensatory increase in LVEDP. The fact that this did not occur is indicated by the behaviour of the EDL in the ischaemic area, and of the LVEDP in the entire ventricle.
The endocardial flow rates during ischaemia were virtually the same in the two groups, with 21 ml min-'/lOO g (EG) and 23 ml mur'/lOO g (CG). The perfusion pressure during ischaemia was slightly higher in the enflurane group-but before the actual administration of enflurane-than in the control animals. The perfusion pressure decreased by 16% approximately in the course of the administration of enflurane. There was no change in this variable in the control group. At the end of the enflurane administration, perfusion pressure was 81 mm Hg, being 78 mm Hg in the control group at the same time. There was no difference between the two groups.
Enflurane not only prevented a further increase in lactate production, but it led to a decrease in lactate output. As lactate production did not increase at the end of ischaemia and after withdrawal of enflurane in spite of an increase in MBF, the difference between both groups could not be explained by intracellular or interstitial lactate retention.
It is very difficult to compare the results obtained in different experimental models and under different experimental conditions. Furthermore, authors differ in their interpretations of the term "critical coronary stenosis". Lowenstein and colleagues (1981) found that halo thane (between 0.5 and 2.0 vol.%) produced no change in regional myocardial ischaemia. A comparison of the two experimental models shows that Lowenstein and colleagues, according to their own definition of the changes in the regional contraction patterns, used a model of mild ischaemia, whereas our own experiments involved more severe ischaemia. They administered a basal anaesthetic of halothane 0.5 vol.% to their animals, but there was no reference to control values without halothane. Hickey and co-workers (1980) , who like us measured the myocardial blood flow and lactate extraction, found that the administration of halothane at 1.2-2.1 ,MAC to dogs with 75% coronary stenosis resulted in severe reductions in endocardial blood flow and lactate production. However, the low diastolic aortic pressure of 42 mm Hg these authors reported would probably prevent a beneficial effect. This may also be the case in the study by Behrenbeck and associates (1980) who carried out a canine study with coronary artery stenosis of approximately 80%. They reported that the administration of 0.5-1.5 MAC of halothane resulted in a significant decrease in the systolic change in wall thickness in the ischaemic area, as an expression of an increase in ischaemia. They attributed the increase in ischaemia to peripheral circulatory effects and to the global depression induced by halothane. Verrier and colleagues (1980) , who also designed a study with coronary stenosis, reported that the administration of halothane 0.8 vol.% to dogs with a low mean aortic pressure of 89 or 84 mm Hg was followed by a reduction in myocardial oxygen consumption and an increase in coronary reserves, but these advantages of halothane were lost when the heart rate was maintained constant by electrical pacing. In our study, however, enflurane did not cause a significant decrease in the heart rate and so a decrease in heart rate was not responsible for the beneficial effects of enflurane.
In conclusion, our study in dogs showed that enflurane may be advantageous during severe myocardial ischaemia. This is indicated by the reduced regional contraction, measured as EDL and AL, the unchanged subendocardial blood flow, and the improved lactate extraction in the ischaemic area.
